Discover
VMD
Viemed Healthcare, Inc.
11.74
2 x 8.41
2 x 14.68
bid
ask
+
0.34
2.98%
2 @ 04:00 PM
11.74 +0.00 (0.00%)
| Ytd | 58.01% | |
| 1y | 67.71% |
11.43
day range
11.86
5.93
52 week range
11.88
| Open | 11.45 | Prev Close | 11.40 | Low | 11.43 | High | 11.86 | Mkt Cap | 450.07M |
| Vol | 268.57K | Avg Vol | 280.84K | EPS | 0.37 | P/E | 31.73 | Forward P/E | 19.57 |
| Beta | 1.44 | Short Ratio | 1.30 | Inst. Own | 66.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 10.01 | 200-d Avg | 8.26 | 1yr Est | 12.27 |
| Income Statement | |||
| Total Revenue | 75.41M | ||
| Revenues (USD) | 75.41M | ||
| Cost of Revenue | 32.59M | ||
| Gross Profit | 42.83M | ||
| Operating Expenses | 38.53M | ||
| Research and Development Expense | 579.00K | ||
| Selling, General and Administrative Expense | 34.79M | ||
| Operating Income | 4.30M | ||
| Interest Expense | 305.00K | ||
| Income Tax Expense | 1.28M | ||
| Net Income | 2.58M | ||
| Net Income Common Stock | 2.58M | ||
| Net Income Common Stock (USD) | 2.58M | ||
| Consolidated Income | 2.71M | ||
| Net Income to Non-Controlling Interests | 131.00K | ||
| Earnings per Basic Share | 0.07 | ||
| Earnings per Basic Share (USD) | 0.07 | ||
| Earnings per Diluted Share | 0.06 | ||
| Earning Before Interest & Taxes (EBIT) | 4.17M | ||
| Earning Before Interest & Taxes (USD) | 4.17M | ||
| Weighted Average Shares | 38.43M | ||
| Weighted Average Shares Diluted | 40.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.76M | ||
| Cash and Equivalents (USD) | 9.76M | ||
| Investments | 2.79M | ||
| Investments Non-Current | 2.79M | ||
| Trade and Non-Trade Receivables | 31.18M | ||
| Current Assets | 49.81M | ||
| Property, Plant & Equipment Net | 79.31M | ||
| Total Assets | 197.36M | ||
| Debt Current | 2.07M | ||
| Total Debt | 12.44M | ||
| Current Liabilities | 40.71M | ||
| Debt Non-Current | 10.37M | ||
| Total Liabilities | 51.57M | ||
| Accumulated Retained Earnings (Deficit) | 105.47M | ||
| Shareholders Equity | 143.86M | ||
| Shareholders Equity (USD) | 143.86M | ||
| Assets Non-Current | 147.55M | ||
| Total Debt (USD) | 12.44M | ||
| Deferred Revenue | 7.48M | ||
| Goodwill and Intangible Assets | 60.16M | ||
| Inventory | 5.18M | ||
| Liabilities Non-Current | 10.86M | ||
| Trade and Non-Trade Payables | 8.57M | ||
| Tax Assets | 5.29M | ||
| Tax Liabilities | 1.04M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.62M | ||
| Net Cash Flow from Financing | -6.32M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.74M | ||
| Capital Expenditure | -5.48M | ||
| Issuance (Purchase) of Equity Shares | -2.91M | ||
| Issuance (Repayment) of Debt Securities | -3.24M | ||
| Net Cash Flow from Investing | -5.48M | ||
| Net Cash Flow from Operations | 8.07M | ||
| Share Based Compensation | 2.45M | ||